Get the Stockscreener App
0.7755
0.10%
-0.0008
After Hours:
.78
0.0045
+0.58%
Genetic Technologies Ltd Adr stock is traded at $0.7755, with a volume of 19,768.
It is down -0.10% in the last 24 hours and down -12.87% over the past month.
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.
See More
Previous Close:
$0.7763
Open:
$0.7758
24h Volume:
19,768
Relative Volume:
0.48
Market Cap:
$2.61M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-1.2839
EPS:
-0.604
Net Cash Flow:
-
1W Performance:
-1.34%
1M Performance:
-12.87%
6M Performance:
-73.17%
1Y Performance:
+1.69%
1-Day Range:
$0.74
$0.7775
1-Week Range:
$0.74
$0.819
52-Week Range:
$0.52
$3.59
Genetic Technologies Ltd Adr Stock (GENE) Company Profile
Name
Genetic Technologies Ltd Adr
Sector
Industry
Phone
-
Address
-
Genetic Technologies Ltd Adr Stock (GENE) Latest News
Genetic Technologies joins "CancerIQ" platform - Investing.com
Genetic Technologies joins "CancerIQ" platform - Investing.com India
Genetic Technologies faces Nasdaq noncompliance issue - Investing.com
Genetic Technologies faces Nasdaq noncompliance issue By Investing.com - Investing.com UK
Genetic Technologies launches geneType on EasyDNA platform - Investing.com
Genetic Technologies sets sights on U.S. market growth - Investing.com India
Genetic Technologies names new CFO and Company Secretary - Investing.com India
Genetic Technologies Ltd. ADR (GENE) Stock: A Year of Market Fluctuations - The InvestChronicle
Genetic Technologies CFO Steps Down By Investing.com - Investing.com India
Genetic Technologies CFO Steps Down By Investing.com - Investing.com
HEICO shares target raised, keeps Buy rating on strong outlook By Investing.com - Investing.com India
Barclays maintains FedEx overweight rating, $350 target By Investing.com - Investing.com
Genetic Technologies CFO Steps Down By Investing.com - Investing.com UK
Energizer stock PT raised to $375 at Deutsche Bank, reflecting revenue growth By Investing.com - Investing.com
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease - GlobeNewswire Inc.
Genetic Technologies to Host Investor Webinar By Investing.com - Investing.com India
Mastercard shareholders vote on board, executive pay, and proposals By Investing.com - Investing.com
Genetic Technologies to Host Investor Webinar By Investing.com - Investing.com
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27 - GlobeNewswire Inc.
Insmed shares target lifted by Evercore ISI on brensocatib optimism By Investing.com - Investing.com UK
Inozyme Pharma reports voting results, re-elects directors By Investing.com - Investing.com
BM Technologies reports annual meeting results By Investing.com - Investing.com
Gilead's HIV prevention trial shows promise with zero infections By Investing.com - Investing.com
FSN E-commerce stock upgraded by ICICI Securities citing growth focus By Investing.com - Investing.com
Crest Nicholson shares target reduced by Deutsche Bank, margin pressures cited By Investing.com - Investing.com
Biomea Fusion stock downgraded at Barclays; price target slashed to $5 from $30 By Investing.com - Investing.com UK
Genetic Technologies Ltd. ADR (GENE) Stock: A Comprehensive 52-Week Review - The InvestChronicle
The Psychology of Genetic Technologies Ltd. ADR Inc. (GENE) Price Performance: Understanding Market Sentiment - The InvestChronicle
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid ... - Investing.com UK
Li-Cycle holdings director Mark Wellings sells shares worth over $36,000 - Investing.com
Hesai Group CFO Louis T. Hsieh steps down By Investing.com - Investing.com
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. ... - The Globe and Mail
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering - GlobeNewswire Inc.
Genetic Technologies Announces $2 Million Registered Direct Offering - GlobeNewswire Inc.
GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market - GlobeNewswire Inc.
The 8 Best Penny Stocks On Webull (June 2024) - The Stock Dork
The Best Biotech Stocks to Buy - Morningstar
6 Best Genomics Stocks to Buy in 2024 - The Motley Fool
GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews.com
TEVA: 3 Smart Pharma Picks Serving Gains - StockNews.com
Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement - Investor's Business Daily
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change - Yahoo Finance
GSK: 3 Pharma Stocks Flashing 'Buy' Signals in December - StockNews.com
Top 5 NASDAQ Genetics Stocks - Investing News Network
GSK: 3 Pharma Stocks on the RiseIt's Time to Buy Now - StockNews.com
A pharmacogenetic study of perampanel: association between rare variants of glutamate receptor genes and outcomes - Frontiers
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it - Stockhead
Gene Slade’s Journey in Mastering Sales and Transforming Businesses - CEOWORLD magazine
Biotech ‘to be worth $US4 trillion’ - Daily Telegraph
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger - Stockhead
Genetic Technologies Ltd Adr Stock (GENE) Financials Data
There is no financial data for Genetic Technologies Ltd Adr (GENE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):